Table 1 Baseline characteristics of patients by allocation

N

18

16

Female: n (%)

13 (72%)

12 (75%)

Age: years (SD)

64.6 (12.1)

56.8 (10.2)

Disease duration: years (SD)

16.7 (10.1)

14.1 (11.9)

DAS (0–10): median score (IQR)

4.3 (3.5,5.2)

3.7 (3.1,4.2)

HAQ score (0–3): median score (IQR)

1.04 (0.48,1.71)

0.75 (0.63,1.13)

BMI: median score (IQR)

27.0 (22.6,32.3)

27.0 (24.8,30.5)

Pharmacological management

Analgesics: n (%)

8 (44%)

6 (38%)

NSAIDs: n (%)

9 (50%)

8 (50%)

DMARDs: n (%)

12 (67%)

14 (88%)

Biologic agent: n (%)

2 (11%)

1 (6%)

Corticosteroid: n (%)

5 (28%)

4 (25%)

Other: n (%)

2 (11%)

2 (13%)

Foot disease

LFIS_IF (0–21): median score (IQR)

13 (12,14)

15 (12,16)

LFIS_AP (0–30) median score (IQR)

21 (16,26)

17 (15,24)

Function

Walking speed (m/s): median score (IQR)

0.70 (0.40,1.09)

0.88 (0.76,1.00)